Conceptus (CPTS) Reports Q3 EPS $0.20, Beats By 11c; Guides Q4 EPS
More News related to CPTS
- Conceptus(R) to Present at the Piper Jaffray 21st Annual Healthcare Conference
- Conceptus(R) to Continue Patent Infringement Suit against Adiana(R) Permanent Contraception System
- SunTrust Downgrades Conceptus (CPTS) to Neutral
- Conceptus(R) to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Essure(R) to Be Highlighted at 18th Annual Congress of the European Society for Gynaecological Endoscopy
More News related to Earnings
- Wunderlich Securities Downgrades Gran Tierra Energy (GTE) to Hold
- Stephens Downgrades Benihana (BNHN) to Equalweight
- UBS Downgrades NRG Energy (NRG) to Neutral; Cuts Target to $26
- Citi Cuts Lukoil (LUKOY) to Hold
- RBC Upgrades Diamond Rock (DRH) to Outperform, Downgrades Hospitality Properties (HPT) to Sector Perform
Conceptus (NASDAQ: CPTS) reports Q3 EPS of $0.20, 11 cents better than the analyst estimate of $0.09. Revenue for the quarter was $34.2 million, which compares to the estimate of $33.10 million.
Sees Q4 EPS-adj. to $0.31 - $0.33 vs. $0.23 consensus. Raises FY09 revenues from $131.9 - $132.4
Related Categories
EarningsStocks Mentioned
+0.09Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
